Sagimet Biosciences (SGMT) Equity Ratio (2023 - 2024)
Sagimet Biosciences (SGMT) has 2 years of Equity Ratio data on record, last reported at 0.98 in Q3 2024.
- For Q3 2024, Equity Ratio rose 2.7% year-over-year to 0.98; the TTM value through Sep 2024 reached 0.98, up 2.7%, while the annual FY2023 figure was 0.94, N/A changed from the prior year.
- Equity Ratio reached 0.98 in Q3 2024 per SGMT's latest filing, up from 0.97 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.98 in Q1 2024 and bottomed at 9.23 in Q2 2023.